Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
3 Quarterly Reports Investors Can't Ignore This Week
09:03pm, Monday, 17'th Jul 2023
Earnings season is always an exciting time to be an investor, with companies finally pulling the curtain back and unveiling what's transpired behind closed doors.
2 Monster Stocks to Buy Without Any Hesitation
05:30am, Monday, 17'th Jul 2023
These two companies -- giants in the worlds of biotech and pharma -- have a great earnings track record. And they both may be about to enter a new era of growth.
2 Warren Buffett Stocks to Buy Hand Over Fist
05:30am, Saturday, 15'th Jul 2023
Amazon shares have climbed this year as cost-cutting efforts started to bear fruit. Johnson & Johnson is spinning off its slowest-growth business -- a move that should spur overall revenue growth.
COMPASS: The Landscape Is Changing Quickly; Risk Is Up And Potential Down
07:10pm, Friday, 14'th Jul 2023
COMPASS: The Landscape Is Changing Quickly; Risk Is Up And Potential Down
Dow Jones Today: Index Up on Healthcare Earnings
04:35pm, Friday, 14'th Jul 2023
Primarily on the strength of UnitedHealth Group's earnings, the Dow Jones gained 125 points, finishing higher every day this week
Johnson & Johnson Poised For A Muted Q2?
10:00am, Friday, 14'th Jul 2023
We expect the company's revenues to come in at $24.6 billion, marginally below the consensus estimate of $24.7 billion.
Johnson & Johnson Sues Doctors Over Studies Linking Talc-Based Products and Cancer
07:57pm, Thursday, 13'th Jul 2023
Company says the studies played a significant role in lawsuits over its Baby Powder and Shower to Shower products.
Johnson & Johnson Letting Nonprofit Distribute Life-Saving Generic Tuberculosis Drug—Greatly Expanding Access In Poorer Countries
01:51pm, Thursday, 13'th Jul 2023
The drug manufacturer faced an online pressure campaign championed by novelist John Green before the announcement Thursday, which lets Stop TB Partnership offer cheaper generic versions of Johnson & J
Is Johnson & Johnson Stock Overvalued?
05:35am, Thursday, 13'th Jul 2023
Johnson & Johnson is a relatively safe stock, and it pays a decent dividend. Its valuation is higher than that of its peers, but so is its history of performance.
3 Dow Stocks That Are Stand-Out Buys for July (and Beyond)
05:06am, Wednesday, 12'th Jul 2023
The Dow Jones Industrial Average has been one of the world's most-followed stock indexes for well over a century. The Dow Jones is composed of 30 historically profitable, time-tested businesses.
Dow Jones Today: Index Jumps 300 Points
05:10pm, Tuesday, 11'th Jul 2023
The Dow Jones led all indexes by moving higher by nearly 1%, as investors anticipate tomorrow's key inflation data.
U.S. FDA classifies recall of J&J's electrosurgical tools as most serious
11:31am, Tuesday, 11'th Jul 2023
The U.S. Food and Drug Administration (FDA) on Tuesday classified the recall of certain electrosurgery tools manufactured by a Johnson & Johnson unit as the most serious, saying their use could lead t
Meet Wall Street's Greatest Dividend Stock: A Small-Cap Company 99.9% of Investors Have Probably Never Heard Of
05:21am, Tuesday, 11'th Jul 2023
When examined over a lengthy timeline, dividend stocks have substantially outperformed their non-paying peers. Only a very small percentage of income stocks are Dividend Kings or have been paying a co
Jurors urged to impose heavy punitive damages in J&J talc trial
06:11pm, Monday, 10'th Jul 2023
Lawyers for a California man who says he developed a rare cancer from exposure to asbestos in Johnson & Johnson's talc-based baby powder on Monday urged a jury to order the company to pay heavy puniti
Johnson & Johnson 2Q financial results could beat even as pharma sales weigh
02:34pm, Monday, 10'th Jul 2023
Johnson & Johnson (NYSE:JNJ) will report its second-quarter 2023 financial results on Thursday, July 20, 2023, with the company expected to generate earnings per share (EPS) for the period of $2.62, u
